/Companies

FluidX Medical Technology

Salt Lake City, US · 1 known investors

Find your way into FluidX Medical Technology

Sign up to see every warm intro you have to FluidX Medical Technology

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the FluidX Medical Technology team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Fluidx Medical Technology develops embolic devices for use in embolization procedures that are designed to be easy to use, controllable, visible, and durable. The company serves interventional physicians and patients requiring embolization treatments.

Founders & leadership

SFShawn Fojtik
Shawn FojtikCo-founderDirector at Control Medical Technology
RSRussell Stewart
Russell StewartCo-founder
LKLawrence Kronick
Lawrence KronickCo-founder
LGLibble Ginster
Libble GinsterPresident & CEO
JM
James McGuckinNamed on SEC filing
GA
Gregory A. FreddeNamed on SEC filing
MD
Michael DakeNamed on SEC filing
KG
Karen GinsterNamed on SEC filing

Investors · 1

Reported raises · per SEC filings

Form D private placements

$14.3M disclosed across 4 rounds · 2020–2024

▶$1.3MraisedMay 2024 · 19 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • MICHAEL DAKEDirector
  • SHAWN PATRICK FOJTIKDirector
  • GREG FREDDEDirector
  • JAMES McGUCKINDirector
  • KAREN GINSTERExecutive Officer, Director
Offering amount
$1.3M
Amount sold
$1.3M
First sale
Mar 2024
Incorporated
Corporation, Utah
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.4MraisedMar 2023 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Shawn Patrick FojtikDirector
  • Gregory A. FreddeDirector
  • James McGuckinDirector
  • Karen GinsterExecutive Officer, Director
  • Lawrence KronickDirector
  • Michael DakeDirector
Offering amount
$2.4M
Amount sold
$2.4M
First sale
Nov 2020
Incorporated
Corporation, Utah
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.6MraisedMar 2023 · 26 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Lawrence KronickDirector
  • Shawn Patrick FojtikDirector
  • James McGuckinDirector
  • Gregory A. FreddeDirector
  • Michael DakeDirector
  • Karen GinsterExecutive Officer, Director
Offering amount
$7.6M
Amount sold
$7.6M
First sale
Sep 2021
Incorporated
Corporation, Utah
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.2MraisedMar 2023 · 13 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Lawrence KronickDirector
  • Karen GinsterExecutive Officer, Director
  • Gregory A. FreddeDirector
  • Michael DakeDirector
  • James McGuckinDirector
  • Shawn Patrick FojtikDirector
Offering amount
$3.2M
Amount sold
$3.2M
First sale
Nov 2020
Incorporated
Corporation, Utah
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

What does FluidX Medical Technology do?
Fluidx Medical Technology develops embolic devices for use in embolization procedures that are designed to be easy to use, controllable, visible, and durable. The company serves interventional physicians and patients requiring embolization treatments.
Who founded FluidX Medical Technology?
FluidX Medical Technology was founded by Shawn Fojtik, Russell Stewart, Lawrence Kronick.
Who are FluidX Medical Technology's investors?
FluidX Medical Technology's investors include MedMountain Ventures.
How much funding has FluidX Medical Technology raised?
FluidX Medical Technology has disclosed $14.3M raised across 4 rounds.
Where is FluidX Medical Technology headquartered?
FluidX Medical Technology is headquartered in Salt Lake City, US.